Ario Health announced the latest release of ArioGPT, its AI-native analytics platform designed to help life sciences teams unlock faster, more confident insights from real-world data. The new version introduces advanced natural language analytics, generative UI for KPIs, and AI-driven cohort discovery—enabling users to explore data, build cohorts, and analyze performance without writing complex SQL queries.

Built on a harmonized, semantically normalized data model, ArioGPT unifies claims, EHR, diagnostics, labs, registries, and unstructured clinical data into a single regulatory-grade real-world evidence (RWE) environment. These capabilities dramatically reduce time-to-insight and help pharmaceutical and biotechnology organizations move seamlessly from data to decision across research, regulatory, medical, and commercial strategy.